Agency for Healthcare Research and Quality (AHRQ). Methods for insulin delivery and glucose monitoring. Comparative Effectiveness Review No. 57. Rockville (MD): AHRQ, July 2012.
Deutsche Diabetes Gesellschaft e.V. (DDG). Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. S3-Leitlinie. October 2015. (AWMF-Leitlinien; volume 057 - 016).
Deutsche Diabetes Gesellschaft e.V. (DDG). Therapie des Typ-1-Diabetes. S3-Leitlinie. September 2011. (AWMF-Leitlinien; volume 057 - 013).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Continuous interstitial glucose monitoring (CGM) with real-time measurement devices in insulin-dependent diabetes mellitus: final report; commission D12-01. March 25, 2015 (IQWiG reports; volume 289).
Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012; (1): CD008101.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.